15.12.11 13:27 Age: 12 Jahre
Eurartesim licensed by the EMA in Nov. 2011
Eurartesim (Dihydroartemisinin/Piperaquin) a novel ACT has been licensed by the EMA (European Medicines Agency) in Nov. 2011. Eruartesim is licensed for the treatment of uncomplicated Plasmodium falciparum malaria in patients above 6 months and a body weight over 5kg. (Reference)